#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Desmoid tumour Hyperinsulinaemic hypoglycaemia Neuroendocrine cell hyperplasia of infancy Pleural mesothelioma malignant Marginal zone lymphoma refractory Hereditary angioedema with C1 esterase inhibitor deficiency Stiff person syndrome Skin angiosarcoma Metabolic disorder Deafness bilateral Choroidal dystrophy Anaplastic thyroid cancer Meningococcal immunisation Hydrocephalus Red blood cell abnormality More trials…

    Learn about Rare Diseases

    Stevens-Johnson syndrome – Life with Disease Breast angiosarcoma metastatic – Diagnostics Thrombotic thrombocytopenic purpura – Trials in Disease Haemophilia B with anti factor IX Choroid melanoma – Trials in Disease Behcet’s syndrome – Trials in Disease Lymphatic malformation – Basic Information Waldenstrom’s macroglobulinaemia recurrent Adrenocortical carcinoma – Life with Disease Sarcoidosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gs-1427 Thiamazole Montelukast Belantamab Mafodotin Pal1-15 Acetate Quinine Dihydrochloride Levonorgestrel COBALAMIN GXV813 177Lu-Rhpsma-10.1 Xanthum Gum GLYCYL-TYROSINE VHB937 Dexamethasone Acetate Ph. Eur. Norepinephrine GSK5458514 Maralixibat Chloride Clindamycin Iph5201 Odevixibat More therapies…

    Learn about Your Condition

    Embolism Transient ischaemic attack Arterial tortuosity syndrome Supranuclear palsy Obsessive-compulsive disorder Biliary tract operation Spinal osteoarthritis Raynaud's phenomenon Underweight Rabies Hyperchylomicronaemia Asplenia Bone metabolism disorder Polyneuropathy Paraesthesia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Obinutuzumab treatment for patients with non-infectious cryoglobulinemia vasculitis who did not respond to or cannot tolerate Rituximab

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cryoglobulinaemia
    Investigated Drugs:
    • Obinutuzumab
    France

  • Study of 177Lu-FAP-2286 alone and with drug combinations for patients with advanced solid tumors including non-small cell lung cancer, breast cancer, and pancreatic cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    • Non-small cell lung cancer
    • Breast cancer metastatic
    Investigated Drugs:
    • 177LU-FAP-2286
    • Calcium Folinate
    • Fluorouracil
    Belgium France Italy Spain

  • Study of abrocitinib oral suspension for children aged 2 years and older with moderate to severe atopic dermatitis to evaluate long-term safety and effectiveness

    Recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Abrocitinib
    Germany Hungary Poland Spain

  • Study of deucravacitinib compared to placebo in adolescents aged 12-17 years with moderate to severe plaque psoriasis

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    Belgium Germany Hungary Italy Poland Romania +1

  • Safety Study of Regulatory T Cells (Treg02) and Tacrolimus Discontinuation in Adult Liver Transplant Recipients

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Liver transplant
    Investigated Drugs:
    • Treg02
    • Paracetamol
    • Tacrolimus
    Germany

  • Study of vaginal pentoxifylline gel PKB171 compared to placebo in couples with mild male infertility due to low sperm count or poor sperm movement

    Recruiting

    4 1
    Investigated Diseases:
    • Infertility male
    Investigated Drugs:
    • Pentoxifylline
    Spain
Previous Page
1 … 134 135 136 137 138 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!